home > news > detailed info

Productive Networking Of Pharmaceutical Leaders At PHARMAP 2022

Pharmaceutical Manufacturing and Packaging Congress

Connecting innovators in the pharmaceutical industry and contributing to further development of ongoing pharmaceutical trends were the main directions of PHARMAP 2022. The Congress gathered pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to exchange experience in digital transformation and discuss innovative solutions and business practices. The Congress was held on June, 20-21, 2022 in Berlin, Germany.

The two-day business program included not only successful networking and interaction between representatives of the pharmaceutical industry, but also panel discussions, sessions, and roundtables related to cutting-edge topics of industry. Pharmaceutical manufacturing and packaging experts from Sandoz, Merck, Novartis, Roche, Samsung Biologics, Pfizer, and other majors presented more than 45 case studies, and their technologies and services.

The first day of PHARMAP 2022 started with the executive opening panel that comprised presentations of leading pharmaceutical providers. Then the agenda comprised a panel discussion, a roundtable and sessions about pharmaceutical anti-counterfeiting and brand protection, innovations in pharmaceutical packaging, transforming pharmaceuticals with robotic solutions and AI and others.

The second day of the Congress embraced topics of advanced data for smart manufacturing, converting to a “batch-less” world with continuous manufacturing, supply chain optimization in pharmaceuticals, and others. The closing panel of the PHARMAP 2022 was concluded with speakers from Novartis, Sanofi, and Phillips Therapeutics discussing how to increase the flexibility and reliability of the supply chain in new realities.

The registration for the next edition of the Pharmaceutical Manufacturing and Packaging Congress 2023 is already open. The Congress will take place in June, 12-13, Switzerland.

Visit the official website for more information:
phone 442037693386
email Estrel Berlin, Sonnenallee 225, Berlin, Germany, 12057
Print this page
Send to a friend
News and Press Releases

Quinten Health Closes its Financing Round to Advance Disease Modelling Platforms and Virtual Twins in Real-World

Paris, September 21st, 2022 – Life Science Newswire – QUINTEN HEALTH, a pioneer in real-world data science, Artificial Intelligence (AI) and Machine Learning (ML) for precision care, today announces that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world, as part of the Quinten Group's €14 million growth equity investment from TECHLIFE CAPITAL and MACSF, essentially dedicated to the healthcare activities of the Quinten group.
More info >>

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement